Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer.
Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH.
Krishnan S, et al. Among authors: das p.
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):762-71. doi: 10.1016/j.ijrobp.2006.05.063.
Int J Radiat Oncol Biol Phys. 2006.
PMID: 17011451
Clinical Trial.